P4 Diagnostix has teamed up with Pierian, a genomics company that provides an analysis platform, to help physician-owned labs with next-generation sequencing.
NGS can pose challenges including overhead costs and insurance reimbursement, Pierian said Oct. 18. The company's partnership with P4 Diagnostix aims to ease those challenges for physician-owned labs specializing in urology, gastroenterology and women's health.
Financial terms of the partnership were not disclosed. The partnership is the second between P4 and Pierian in recent weeks.